Global Single Nucleotide Polymorphism (SNP) Genotyping Market Research Report 2025(Status and Outlook)

Report Overview

Single Nucleotide Polymorphism (SNP) genotyping refers to the process of identifying and analyzing variations in a single nucleotide base pair at specific locations in the genome, which are critical for understanding genetic diversity, disease susceptibility, drug response, and evolutionary biology. This technology is widely used in pharmacogenomics, agricultural biotechnology, and personalized medicine, leveraging methods such as microarray-based assays, PCR, next-generation sequencing (NGS), and bead-based techniques to detect SNPs with high accuracy and throughput. The market is driven by increasing demand for precision medicine, declining sequencing costs, and advancements in bioinformatics, while challenges include data interpretation complexities and ethical concerns surrounding genetic privacy. Key applications span diagnostics, drug development, and ancestry testing, with major players including Illumina, Thermo Fisher Scientific, and Agilent Technologies competing in a rapidly evolving landscape.

The global Single Nucleotide Polymorphism (SNP) Genotyping market size was estimated at USD 30204.02 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 21.31% during the forecast period.

This report provides a deep insight into the global Single Nucleotide Polymorphism (SNP) Genotyping market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Single Nucleotide Polymorphism (SNP) Genotyping Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Single Nucleotide Polymorphism (SNP) Genotyping market in any manner.

Global Single Nucleotide Polymorphism (SNP) Genotyping Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Illumina

Affymetrix

Applied Biosystems

Agilent Technologies

Beckman Coulter

Roche

Qiagen

Luminex Corporation

Enzo Life Sciences

Bio-rad

Sequenom

Ocimum Biosolutions

GE Healthcare

GenScript

Douglas Scientific

BGI

Beijing Sunbiotech

HuaGene Biotech

Generay Biotech

Benegene

Shanghai Biochip

GENESKY

HD Biosciences

Market Segmentation (by Type)

Transversion

Transition

Single Nucleotide Polymorphism (SNP)

Market Segmentation (by Application)

Diagnostics

Animal

Plant

Research

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Single Nucleotide Polymorphism (SNP) Genotyping Market

Overview of the regional outlook of the Single Nucleotide Polymorphism (SNP) Genotyping Market:

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Single Nucleotide Polymorphism (SNP) Genotyping Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Single Nucleotide Polymorphism (SNP) Genotyping, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Single Nucleotide Polymorphism (SNP) Genotyping
1.2 Key Market Segments
1.2.1 Single Nucleotide Polymorphism (SNP) Genotyping Segment by Type
1.2.2 Single Nucleotide Polymorphism (SNP) Genotyping Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Single Nucleotide Polymorphism (SNP) Genotyping Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Product Life Cycle
3.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Company (2020-2025)
3.4 Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Single Nucleotide Polymorphism (SNP) Genotyping Company Headquarters, Area Served, Product Type
3.6 Single Nucleotide Polymorphism (SNP) Genotyping Market Competitive Situation and Trends
3.6.1 Single Nucleotide Polymorphism (SNP) Genotyping Market Concentration Rate
3.6.2 Global 5 and 10 Largest Single Nucleotide Polymorphism (SNP) Genotyping Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Single Nucleotide Polymorphism (SNP) Genotyping Value Chain Analysis
4.1 Single Nucleotide Polymorphism (SNP) Genotyping Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 The Development and Dynamics of Single Nucleotide Polymorphism (SNP) Genotyping Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Porter's Five Forces Analysis
6 Single Nucleotide Polymorphism (SNP) Genotyping Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Market Share by Type (2020-2025)
6.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Type (2021-2025)
7 Single Nucleotide Polymorphism (SNP) Genotyping Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size (M USD) by Application (2020-2025)
7.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Sales Growth Rate by Application (2020-2025)
8 Single Nucleotide Polymorphism (SNP) Genotyping Market Segmentation by Region
8.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region
8.1.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region
8.1.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Market Share by Region
8.2 North America
8.2.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Illumina
9.1.1 Illumina Basic Information
9.1.2 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
9.1.3 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
9.1.4 Illumina SWOT Analysis
9.1.5 Illumina Business Overview
9.1.6 Illumina Recent Developments
9.2 Affymetrix
9.2.1 Affymetrix Basic Information
9.2.2 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
9.2.3 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
9.2.4 Affymetrix SWOT Analysis
9.2.5 Affymetrix Business Overview
9.2.6 Affymetrix Recent Developments
9.3 Applied Biosystems
9.3.1 Applied Biosystems Basic Information
9.3.2 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
9.3.3 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
9.3.4 Applied Biosystems SWOT Analysis
9.3.5 Applied Biosystems Business Overview
9.3.6 Applied Biosystems Recent Developments
9.4 Agilent Technologies
9.4.1 Agilent Technologies Basic Information
9.4.2 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
9.4.3 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
9.4.4 Agilent Technologies Business Overview
9.4.5 Agilent Technologies Recent Developments
9.5 Beckman Coulter
9.5.1 Beckman Coulter Basic Information
9.5.2 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
9.5.3 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
9.5.4 Beckman Coulter Business Overview
9.5.5 Beckman Coulter Recent Developments
9.6 Roche
9.6.1 Roche Basic Information
9.6.2 Roche Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
9.6.3 Roche Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
9.6.4 Roche Business Overview
9.6.5 Roche Recent Developments
9.7 Qiagen
9.7.1 Qiagen Basic Information
9.7.2 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
9.7.3 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
9.7.4 Qiagen Business Overview
9.7.5 Qiagen Recent Developments
9.8 Luminex Corporation
9.8.1 Luminex Corporation Basic Information
9.8.2 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
9.8.3 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
9.8.4 Luminex Corporation Business Overview
9.8.5 Luminex Corporation Recent Developments
9.9 Enzo Life Sciences
9.9.1 Enzo Life Sciences Basic Information
9.9.2 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
9.9.3 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
9.9.4 Enzo Life Sciences Business Overview
9.9.5 Enzo Life Sciences Recent Developments
9.10 Bio-rad
9.10.1 Bio-rad Basic Information
9.10.2 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
9.10.3 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
9.10.4 Bio-rad Business Overview
9.10.5 Bio-rad Recent Developments
9.11 Sequenom
9.11.1 Sequenom Basic Information
9.11.2 Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
9.11.3 Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
9.11.4 Sequenom Business Overview
9.11.5 Sequenom Recent Developments
9.12 Ocimum Biosolutions
9.12.1 Ocimum Biosolutions Basic Information
9.12.2 Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
9.12.3 Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
9.12.4 Ocimum Biosolutions Business Overview
9.12.5 Ocimum Biosolutions Recent Developments
9.13 GE Healthcare
9.13.1 GE Healthcare Basic Information
9.13.2 GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
9.13.3 GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
9.13.4 GE Healthcare Business Overview
9.13.5 GE Healthcare Recent Developments
9.14 GenScript
9.14.1 GenScript Basic Information
9.14.2 GenScript Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
9.14.3 GenScript Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
9.14.4 GenScript Business Overview
9.14.5 GenScript Recent Developments
9.15 Douglas Scientific
9.15.1 Douglas Scientific Basic Information
9.15.2 Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
9.15.3 Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
9.15.4 Douglas Scientific Business Overview
9.15.5 Douglas Scientific Recent Developments
9.16 BGI
9.16.1 BGI Basic Information
9.16.2 BGI Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
9.16.3 BGI Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
9.16.4 BGI Business Overview
9.16.5 BGI Recent Developments
9.17 Beijing Sunbiotech
9.17.1 Beijing Sunbiotech Basic Information
9.17.2 Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
9.17.3 Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
9.17.4 Beijing Sunbiotech Business Overview
9.17.5 Beijing Sunbiotech Recent Developments
9.18 HuaGene Biotech
9.18.1 HuaGene Biotech Basic Information
9.18.2 HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
9.18.3 HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
9.18.4 HuaGene Biotech Business Overview
9.18.5 HuaGene Biotech Recent Developments
9.19 Generay Biotech
9.19.1 Generay Biotech Basic Information
9.19.2 Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
9.19.3 Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
9.19.4 Generay Biotech Business Overview
9.19.5 Generay Biotech Recent Developments
9.20 Benegene
9.20.1 Benegene Basic Information
9.20.2 Benegene Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
9.20.3 Benegene Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
9.20.4 Benegene Business Overview
9.20.5 Benegene Recent Developments
9.21 Shanghai Biochip
9.21.1 Shanghai Biochip Basic Information
9.21.2 Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
9.21.3 Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
9.21.4 Shanghai Biochip Business Overview
9.21.5 Shanghai Biochip Recent Developments
9.22 GENESKY
9.22.1 GENESKY Basic Information
9.22.2 GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
9.22.3 GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
9.22.4 GENESKY Business Overview
9.22.5 GENESKY Recent Developments
9.23 HD Biosciences
9.23.1 HD Biosciences Basic Information
9.23.2 HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Product Overview
9.23.3 HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Product Market Performance
9.23.4 HD Biosciences Business Overview
9.23.5 HD Biosciences Recent Developments
10 Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast by Region
10.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast
10.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast by Country
10.2.3 Asia Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast by Region
10.2.4 South America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Single Nucleotide Polymorphism (SNP) Genotyping by Country
11 Forecast Market by Type and by Application (2026-2033)
11.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast by Type (2026-2033)
11.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast by Application (2026-2033)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings